Pinealon

Research

Pinealon

Aliases
Glu-Asp-Arg tripeptide
Administration
Intranasal (research), Subcutaneous injection (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Effects are generally described as subtle, consistent with its proposed cellular-level mechanism.

  2. 2

    3–4 Weeks

    Some users report a modest sense of improved mental clarity.

  3. 3

    5–7 Weeks

    Continued use is generally associated with a steady rather than building effect.

  4. 4

    8–10 Weeks

    Limited human data makes a longer-term felt timeline difficult to characterize.

  5. 5

    11–15 Weeks

    Available evidence does not describe outcomes at this duration.

  6. 6

    16–20 Weeks

    No well-established human timeline exists to reference at this stage.

  7. 7

    21–24 Weeks

    Any effect assessment at this duration would rely on personal observation given limited research.

⚠️ Research context only. This is not medical advice and results are not guaranteed.